Literature DB >> 17352104

Rising ELISPOT count prior to the onset of symptoms of full-blown tuberculosis disease.

I M O Adetifa1, R Brookes, M D Lugos, B C de Jong, M Antonio, R A Adegbola, P C Hill.   

Abstract

The relationship between the T-cell response to mycobacterial antigens and the likelihood of progression to disease has not been defined. We report a rapidly rising ELISPOT count in a 55-year-old man with evidence of Mycobacterium tuberculosis infection prior to the onset of symptoms of disease. This case illustrates the possible utility of quantitative changes in the ELISPOT count in predicting progression from M. tuberculosis infection to disease.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17352104

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


  6 in total

1.  Two-Year Follow-up Study of Mycobacterium tuberculosis Antigen-Driven IFN-γ Responses and Macrophage sCD14 Levels After Tuberculosis Contact.

Authors:  Magdalena Druszczynska; Marcin Wlodarczyk; Grzegorz Kielnierowski; Malwina Kawka; Wieslawa Rudnicka
Journal:  Indian J Microbiol       Date:  2016-02-23       Impact factor: 2.461

2.  Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases.

Authors:  Ifedayo M O Adetifa; Martin O C Ota; Brigitte Walther; Abdulrahman S Hammond; Moses D Lugos; David J Jeffries; Simon A Donkor; Richard A Adegbola; Philip C Hill
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

3.  Association of quantitative interferon-γ responses with the progression of naturally acquired Mycobacterium bovis infection in wild European badgers (Meles meles).

Authors:  Alexandra J Tomlinson; Mark A Chambers; Robbie A McDonald; Richard J Delahay
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

4.  The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa.

Authors:  Hassan Mahomed; Tony Hawkridge; Suzanne Verver; Deborah Abrahams; Lawrence Geiter; Mark Hatherill; Rodney Ehrlich; Willem A Hanekom; Gregory D Hussey
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

5.  IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia.

Authors:  Helena del Corral; Sara C París; Nancy D Marín; Diana M Marín; Lucelly López; Hanna M Henao; Teresita Martínez; Liliana Villa; Luis F Barrera; Blanca L Ortiz; María E Ramírez; Carlos J Montes; María C Oquendo; Lisandra M Arango; Felipe Riaño; Carlos Aguirre; Alberto Bustamante; John T Belisle; Karen Dobos; Gloria I Mejía; Margarita R Giraldo; Patrick J Brennan; Jaime Robledo; María P Arbeláez; Carlos A Rojas; Luis F García
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

6.  T-SPOT.TB responses during treatment of pulmonary tuberculosis.

Authors:  Samantha Ribeiro; Kelly Dooley; Judith Hackman; Carla Loredo; Anne Efron; Richard E Chaisson; Marcus B Conde; Neio Boechat; Susan E Dorman
Journal:  BMC Infect Dis       Date:  2009-02-28       Impact factor: 3.090
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.